on February 3, 2005
Published online before print February 3, 2005, doi: 10.1161/01.ATV.0000158310.64498.ac
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 10, 2004
Accepted on January 18, 2005
Lymphocytes Are Not Required for the Rapid Onset of Coronary Heart Disease in Scavenger Receptor Class B Type I/Apolipoprotein E Double Knockout Mice
Sharon L. Karackattu ;
From the Department of Biology (S.L.K., M.K.), Massachusetts Institute of Technology, Cambridge; and Division of Cardiology Department of Medicine (M.H.P.), Massachusetts General Hospital and Harvard Medical School, Boston, Mass.
* To whom correspondence should be addressed. E-mail: krieger{at}mit.edu.
Objective--Scavenger receptor class B type I (SR-BI)/apolipoprotein E (apoE) double knockout (dKO) mice exhibit many features of human coronary heart disease (CHD), including occlusive coronary atherosclerosis, cardiac hypertrophy, myocardial infarctions, and premature death. Here we determined the influence of B and T lymphocytes, which can contribute to atherosclerosis, ischemia-reperfusion injury, and cardiomyocyte death, on pathology in dKO mice.
Method and Results--The lymphocyte-deficient SR-BI/apoE/RAG2 triple knockout mice and corresponding dKO controls generated for this study exhibited essentially identical lipid-rich coronary occlusions, myocardial infarctions, cardiac dysfunction, and premature death (average lifespans 41.6±0.6 and 42.0±0.5 days, respectively).
Conclusions--B and T lymphocytes and associated immunoglobulin-mediated inflammation are not essential for the development and progression of CHD in dKO mice. Strikingly, the dKO mice bred for this study (mixed C57BL/6xSV129xBALB/c background; strain 2) compared with the previously described dKO mice (75:25 C57BL/6:SV129 background; strain 1) had a shorter mean lifespan and steeper survival curve, characteristics especially attractive for studying the effects of environmental, pharmacological, and genetic manipulations on cardiac pathophysiology.
Key words: atherosclerosis • HDL receptor • myocardial infarction • RAG2 • echocardiography
This article has been cited by other articles:
 |
|
 |
|
  V. S. Dole, J. Matuskova, E. Vasile, A. Yesilaltay, W. Bergmeier, M. Bernimoulin, D. D. Wagner, and M. Krieger Thrombocytopenia and Platelet Abnormalities in High-Density Lipoprotein Receptor-Deficient Mice Arterioscler Thromb Vasc Biol, June 1, 2008; 28(6): 1111 - 1116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. F. Nieland, J. T. Shaw, F. A. Jaipuri, Z. Maliga, J. L. Duffner, A. N. Koehler, and M. Krieger Influence of HDL-cholesterol-elevating drugs on the in vitro activity of the HDL receptor SR-BI J. Lipid Res., August 1, 2007; 48(8): 1832 - 1845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Karackattu, B. Trigatti, and M. Krieger Hepatic Lipase Deficiency Delays Atherosclerosis, Myocardial Infarction, and Cardiac Dysfunction and Extends Lifespan in SR-BI/Apolipoprotein E Double Knockout Mice Arterioscler Thromb Vasc Biol, March 1, 2006; 26(3): 548 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Zhang, M. H. Picard, E. Vasile, Y. Zhu, R. L. Raffai, K. H. Weisgraber, and M. Krieger Diet-Induced Occlusive Coronary Atherosclerosis, Myocardial Infarction, Cardiac Dysfunction, and Premature Death in Scavenger Receptor Class B Type I-Deficient, Hypomorphic Apolipoprotein ER61 Mice Circulation, June 28, 2005; 111(25): 3457 - 3464. [Abstract] [Full Text] [PDF]
|
|